WF
NVO

WealthTrust Fairport’s Novo Nordisk NVO Stock Holding History

WealthTrust Fairport’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-600
Closed -$14K – 490
2018
Q3 		$14K Hold
600
– – ﹤0.01% 364
2018
Q2 		$14K Hold
600
– – ﹤0.01% 352
2018
Q1 		$15K Buy
+600
New +$15.8K ﹤0.01% 360
2015
Q1 		– Sell
-200
Closed -$4K – 302
2014
Q4 		$4K Hold
200
– – ﹤0.01% 401
2014
Q3 		$5K Hold
200
– – ﹤0.01% 293
2014
Q2 		$5K Buy
+200
New +$4.42K ﹤0.01% 266

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

WealthTrust Fairport's NVO Position: Q4 2018 in Review

WealthTrust Fairport sold out of Novo Nordisk (NVO) in Q4 2018, closing a stake of 600 shares — an estimated $14K sold.

WealthTrust Fairport first reported a position in NVO in Q2 2014 and held it in 6 quarters. The position peaked at $15K in Q1 2018. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.

  • WealthTrust Fairport reported no remaining Novo Nordisk position as of Q4 2018 after selling out during the quarter.
  • WealthTrust Fairport sold 600 Novo Nordisk shares in Q4 2018, an estimated $14K.
  • WealthTrust Fairport first reported a position in Novo Nordisk in Q2 2014 and held it in 6 quarters.
  • WealthTrust Fairport's Novo Nordisk position peaked at $15K in Q1 2018.
  • 550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.

Based on WealthTrust Fairport's 13F filing for Q4 2018, filed 25 Feb 2019.